Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

NOVT vs COHR vs MKSI vs VIAV

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NOVT
Novanta Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$4.86B
5Y Perf.+32.7%
COHR
Coherent, Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$50.62B
5Y Perf.+571.6%
MKSI
MKS Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$20.25B
5Y Perf.+184.8%
VIAV
Viavi Solutions Inc.

Communication Equipment

TechnologyNASDAQ • US
Market Cap$11.81B
5Y Perf.+340.5%

NOVT vs COHR vs MKSI vs VIAV — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NOVT logoNOVT
COHR logoCOHR
MKSI logoMKSI
VIAV logoVIAV
IndustryHardware, Equipment & PartsHardware, Equipment & PartsHardware, Equipment & PartsCommunication Equipment
Market Cap$4.86B$50.62B$20.25B$11.81B
Revenue (TTM)$981M$1.81T$4.07B$1.37B
Net Income (TTM)$54M$191.68B$327M$-55M
Gross Margin44.4%0.1%45.2%55.7%
Operating Margin11.9%0.0%14.8%8.2%
Forward P/E38.2x59.5x30.4x55.2x
Total Debt$342M$3.89B$4.69B$692M
Cash & Equiv.$381M$909M$675M$424M

NOVT vs COHR vs MKSI vs VIAVLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NOVT
COHR
MKSI
VIAV
StockMay 20May 26Return
Novanta Inc. (NOVT)100132.7+32.7%
Coherent, Inc. (COHR)100671.6+571.6%
MKS Inc. (MKSI)100284.8+184.8%
Viavi Solutions Inc. (VIAV)100440.5+340.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: NOVT vs COHR vs MKSI vs VIAV

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: COHR leads in 3 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. MKS Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. VIAV also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
NOVT
Novanta Inc.
The Defensive Pick

NOVT is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.

  • Lower volatility, beta 2.02, Low D/E 26.0%, current ratio 3.69x
  • PEG 11.61 vs VIAV's 12.09
Best for: sleep-well-at-night and valuation efficiency
COHR
Coherent, Inc.
The Growth Play

COHR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 23.4%, EPS growth 71.7%, 3Y rev CAGR 20.5%
  • 14.7% 10Y total return vs NOVT's 8.5%
  • 23.4% revenue growth vs NOVT's 3.3%
  • 10.6% margin vs VIAV's -4.0%
Best for: growth exposure and long-term compounding
MKSI
MKS Inc.
The Income Pick

MKSI is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 0 yrs, beta 2.64, yield 0.3%
  • Beta 2.64, yield 0.3%, current ratio 2.71x
  • Lower P/E (30.4x vs 55.2x)
  • 0.3% yield, vs COHR's 0.0%, (2 stocks pay no dividend)
Best for: income & stability and defensive
VIAV
Viavi Solutions Inc.
The Defensive Choice

VIAV is the clearest fit if your priority is stability and momentum.

  • Beta 1.54 vs COHR's 2.79
  • +466.6% vs NOVT's +14.6%
Best for: stability and momentum
See the full category breakdown
CategoryWinnerWhy
GrowthCOHR logoCOHR23.4% revenue growth vs NOVT's 3.3%
ValueMKSI logoMKSILower P/E (30.4x vs 55.2x)
Quality / MarginsCOHR logoCOHR10.6% margin vs VIAV's -4.0%
Stability / SafetyVIAV logoVIAVBeta 1.54 vs COHR's 2.79
DividendsMKSI logoMKSI0.3% yield, vs COHR's 0.0%, (2 stocks pay no dividend)
Momentum (1Y)VIAV logoVIAV+466.6% vs NOVT's +14.6%
Efficiency (ROA)COHR logoCOHR4.4% ROA vs VIAV's -2.3%, ROIC 3.6% vs 5.5%

NOVT vs COHR vs MKSI vs VIAV — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NOVTNovanta Inc.
FY 2025
Robotics and Automation
32.5%$319M
Advanced Surgery
24.7%$242M
Precision Medicine
24.2%$237M
Precision Manufacturing
18.6%$182M
COHRCoherent, Inc.
FY 2025
Lasers Segment
60.1%$1.4B
Materials Segment
39.9%$954M
MKSIMKS Inc.
FY 2025
Product
87.4%$3.4B
Service
12.6%$495M
VIAVViavi Solutions Inc.
FY 2025
Product
84.1%$912M
Service
15.9%$172M

NOVT vs COHR vs MKSI vs VIAV — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCOHRLAGGINGVIAV

Income & Cash Flow (Last 12 Months)

COHR leads this category, winning 3 of 6 comparable metrics.

COHR is the larger business by revenue, generating $1.81T annually — 1846.3x NOVT's $981M. COHR is the more profitable business, keeping 10.6% of every revenue dollar as net income compared to VIAV's -4.0%. On growth, COHR holds the edge at +1204.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNOVT logoNOVTNovanta Inc.COHR logoCOHRCoherent, Inc.MKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…
RevenueTrailing 12 months$981M$1.81T$4.1B$1.4B
EBITDAEarnings before interest/tax$179M$913M$945M$207M
Net IncomeAfter-tax profit$54M$191.7B$327M-$55M
Free Cash FlowCash after capex$48M-$537.2B$401M$46M
Gross MarginGross profit ÷ Revenue+44.4%+0.1%+45.2%+55.7%
Operating MarginEBIT ÷ Revenue+11.9%+0.0%+14.8%+8.2%
Net MarginNet income ÷ Revenue+5.5%+10.6%+8.0%-4.0%
FCF MarginFCF ÷ Revenue+4.9%-29.7%+9.8%+3.3%
Rev. Growth (YoY)Latest quarter vs prior year+8.5%+1204.5%+15.2%+42.8%
EPS Growth (YoY)Latest quarter vs prior year-2.2%+11190.8%+53.2%-70.2%
COHR leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — NOVT and MKSI each lead in 3 of 7 comparable metrics.

At 68.8x trailing earnings, MKSI trades at a 80% valuation discount to VIAV's 340.3x P/E. Adjusting for growth (PEG ratio), NOVT offers better value at 28.13x vs VIAV's 74.57x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNOVT logoNOVTNovanta Inc.COHR logoCOHRCoherent, Inc.MKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…
Market CapShares × price$4.9B$50.6B$20.2B$11.8B
Enterprise ValueMkt cap + debt − cash$4.8B$53.6B$24.3B$12.1B
Trailing P/EPrice ÷ TTM EPS92.71x-613.83x68.83x340.33x
Forward P/EPrice ÷ next-FY EPS est.38.25x59.48x30.36x55.18x
PEG RatioP/E ÷ EPS growth rate28.13x74.57x
EV / EBITDAEnterprise value multiple27.00x48.61x26.70x90.43x
Price / SalesMarket cap ÷ Revenue4.96x8.71x5.15x10.89x
Price / BookPrice ÷ Book value/share3.81x5.83x7.49x14.77x
Price / FCFMarket cap ÷ FCF100.38x262.58x40.74x190.52x
Evenly matched — NOVT and MKSI each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

NOVT leads this category, winning 6 of 9 comparable metrics.

MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-7 for VIAV. NOVT carries lower financial leverage with a 0.26x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), COHR scores 7/9 vs VIAV's 5/9, reflecting strong financial health.

MetricNOVT logoNOVTNovanta Inc.COHR logoCOHRCoherent, Inc.MKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…
ROE (TTM)Return on equity+4.1%+6.9%+12.2%-6.9%
ROA (TTM)Return on assets+3.0%+4.4%+3.7%-2.3%
ROICReturn on invested capital+7.4%+3.6%+6.5%+5.5%
ROCEReturn on capital employed+8.3%+4.2%+7.2%+4.9%
Piotroski ScoreFundamental quality 0–95765
Debt / EquityFinancial leverage0.26x0.46x1.73x0.89x
Net DebtTotal debt minus cash-$39M$3.0B$4.0B$269M
Cash & Equiv.Liquid assets$381M$909M$675M$424M
Total DebtShort + long-term debt$342M$3.9B$4.7B$692M
Interest CoverageEBIT ÷ Interest expense4.89x0.01x2.84x2.70x
NOVT leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

COHR leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in COHR five years ago would be worth $50,156 today (with dividends reinvested), compared to $10,573 for NOVT. Over the past 12 months, VIAV leads with a +466.6% total return vs NOVT's +14.6%. The 3-year compound annual growth rate (CAGR) favors COHR at 114.9% vs NOVT's -5.3% — a key indicator of consistent wealth creation.

MetricNOVT logoNOVTNovanta Inc.COHR logoCOHRCoherent, Inc.MKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…
YTD ReturnYear-to-date+22.6%+64.3%+78.8%+181.3%
1-Year ReturnPast 12 months+14.6%+358.5%+306.1%+466.6%
3-Year ReturnCumulative with dividends-15.2%+892.8%+266.0%+461.0%
5-Year ReturnCumulative with dividends+5.7%+401.6%+66.5%+212.0%
10-Year ReturnCumulative with dividends+853.7%+1467.0%+750.6%+715.5%
CAGR (3Y)Annualised 3-year return-5.3%+114.9%+54.1%+77.7%
COHR leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MKSI and VIAV each lead in 1 of 2 comparable metrics.

VIAV is the less volatile stock with a 1.54 beta — it tends to amplify market swings less than COHR's 2.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MKSI currently trades 92.0% from its 52-week high vs VIAV's 84.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNOVT logoNOVTNovanta Inc.COHR logoCOHRCoherent, Inc.MKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…
Beta (5Y)Sensitivity to S&P 5002.02x2.79x2.64x1.54x
52-Week HighHighest price in past year$149.95$364.80$326.83$60.43
52-Week LowLowest price in past year$98.27$67.30$71.49$8.87
% of 52W HighCurrent price vs 52-week peak+90.9%+87.5%+92.0%+84.5%
RSI (14)Momentum oscillator 0–10062.664.465.366.7
Avg Volume (50D)Average daily shares traded375K6.8M1.2M6.3M
Evenly matched — MKSI and VIAV each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — MKSI and VIAV each lead in 1 of 2 comparable metrics.

Analyst consensus: NOVT as "Buy", COHR as "Buy", MKSI as "Buy", VIAV as "Buy". Consensus price targets imply 10.1% upside for NOVT (target: $150) vs -36.8% for VIAV (target: $32). MKSI is the only dividend payer here at 0.29% yield — a key consideration for income-focused portfolios.

MetricNOVT logoNOVTNovanta Inc.COHR logoCOHRCoherent, Inc.MKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$150.00$252.50$272.86$32.25
# AnalystsCovering analysts3292919
Dividend YieldAnnual dividend ÷ price+0.0%+0.3%
Dividend StreakConsecutive years of raises001
Dividend / ShareAnnual DPS$0.07$0.87
Buyback YieldShare repurchases ÷ mkt cap+0.8%+0.1%+0.2%+0.1%
Evenly matched — MKSI and VIAV each lead in 1 of 2 comparable metrics.
Key Takeaway

COHR leads in 2 of 6 categories (Income & Cash Flow, Total Returns). NOVT leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallCoherent, Inc. (COHR)Leads 2 of 6 categories
Loading custom metrics...

NOVT vs COHR vs MKSI vs VIAV: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NOVT or COHR or MKSI or VIAV a better buy right now?

For growth investors, Coherent, Inc.

(COHR) is the stronger pick with 23. 4% revenue growth year-over-year, versus 3. 3% for Novanta Inc. (NOVT). MKS Inc. (MKSI) offers the better valuation at 68. 8x trailing P/E (30. 4x forward), making it the more compelling value choice. Analysts rate Novanta Inc. (NOVT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NOVT or COHR or MKSI or VIAV?

On trailing P/E, MKS Inc.

(MKSI) is the cheapest at 68. 8x versus Viavi Solutions Inc. at 340. 3x. On forward P/E, MKS Inc. is actually cheaper at 30. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Novanta Inc. wins at 11. 61x versus Viavi Solutions Inc. 's 12. 09x.

03

Which is the better long-term investment — NOVT or COHR or MKSI or VIAV?

Over the past 5 years, Coherent, Inc.

(COHR) delivered a total return of +401. 6%, compared to +5. 7% for Novanta Inc. (NOVT). Over 10 years, the gap is even starker: COHR returned +1467% versus VIAV's +715. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NOVT or COHR or MKSI or VIAV?

By beta (market sensitivity over 5 years), Viavi Solutions Inc.

(VIAV) is the lower-risk stock at 1. 54β versus Coherent, Inc. 's 2. 79β — meaning COHR is approximately 81% more volatile than VIAV relative to the S&P 500. On balance sheet safety, Novanta Inc. (NOVT) carries a lower debt/equity ratio of 26% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — NOVT or COHR or MKSI or VIAV?

By revenue growth (latest reported year), Coherent, Inc.

(COHR) is pulling ahead at 23. 4% versus 3. 3% for Novanta Inc. (NOVT). On earnings-per-share growth, the picture is similar: Viavi Solutions Inc. grew EPS 225. 0% year-over-year, compared to -16. 9% for Novanta Inc.. Over a 3-year CAGR, COHR leads at 20. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NOVT or COHR or MKSI or VIAV?

MKS Inc.

(MKSI) is the more profitable company, earning 7. 5% net margin versus 0. 8% for Coherent, Inc. — meaning it keeps 7. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MKSI leads at 14. 4% versus 6. 5% for VIAV. At the gross margin level — before operating expenses — VIAV leads at 56. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NOVT or COHR or MKSI or VIAV more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Novanta Inc. (NOVT) is the more undervalued stock at a PEG of 11. 61x versus Viavi Solutions Inc. 's 12. 09x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, MKS Inc. (MKSI) trades at 30. 4x forward P/E versus 59. 5x for Coherent, Inc. — 29. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NOVT: 10. 1% to $150. 00.

08

Which pays a better dividend — NOVT or COHR or MKSI or VIAV?

In this comparison, MKSI (0.

3% yield) pays a dividend. NOVT, COHR, VIAV do not pay a meaningful dividend and should not be held primarily for income.

09

Is NOVT or COHR or MKSI or VIAV better for a retirement portfolio?

For long-horizon retirement investors, Coherent, Inc.

(COHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1467% 10Y return). MKS Inc. (MKSI) carries a higher beta of 2. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (COHR: +1467%, MKSI: +750. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NOVT and COHR and MKSI and VIAV?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NOVT is a small-cap quality compounder stock; COHR is a mid-cap high-growth stock; MKSI is a mid-cap quality compounder stock; VIAV is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NOVT

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

COHR

High-Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 60223%
  • Net Margin > 6%
Run This Screen
Stocks Like

MKSI

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 5%
Run This Screen
Stocks Like

VIAV

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 21%
  • Gross Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NOVT and COHR and MKSI and VIAV on the metrics below

Revenue Growth>
%
(NOVT: 8.5% · COHR: 120446.5%)
Net Margin>
%
(NOVT: 5.5% · COHR: 10.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.